BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26662570)

  • 1. Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma.
    Ye P; Qu CF; Hu XL
    Tumour Biol; 2016 May; 37(5):6893-904. PubMed ID: 26662570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The insulin-like growth factor-1 and expression of its binding protein‑3 in chronic hepatitis C and hepatocellular carcinoma.
    Adamek A; Kasprzak A; Mikoś H; Przybyszewska W; Seraszek-Jaros A; Czajka A; Sterzyńska K; Mozer-Lisewska I
    Oncol Rep; 2013 Sep; 30(3):1337-45. PubMed ID: 23784592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
    Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
    Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-3, in association with IGF-1 receptor, can predict prognosis in squamous cell carcinoma of the head and neck.
    Sun JM; Jun HJ; Ko YH; Park YH; Ahn YC; Son YI; Baek JH; Park K; Ahn MJ
    Oral Oncol; 2011 Aug; 47(8):714-9. PubMed ID: 21708479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
    Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY
    Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
    Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W
    Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGFBP3 gene promoter methylation analysis and its association with clinicopathological characteristics of colorectal carcinoma.
    Kumar A; Singh P; Pandey A; Gosipatala SB
    Mol Biol Rep; 2020 Sep; 47(9):6919-6927. PubMed ID: 32929656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of IGF-1R in esophageal squamous cell carcinoma and the effect of its silencing by siRNA on the proliferation of esophageal cancer EC9706 cells in vitro].
    Ma W; Li W; Fan QX; Wang LX; Wang RL; Lu SX
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):609-12. PubMed ID: 22325222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer.
    Hirakawa T; Yashiro M; Murata A; Hirata K; Kimura K; Amano R; Yamada N; Nakata B; Hirakawa K
    BMC Cancer; 2013 Aug; 13():392. PubMed ID: 23962053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.
    Rinaldi S; Biessy C; Hernandez M; Lesueur F; dos-Santos-Silva I; Rice MS; Lajous M; Lopez-Ridaura R; Torres-Mejía G; Romieu I
    Int J Cancer; 2014 Mar; 134(6):1436-44. PubMed ID: 24037648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations of insulin-like growth factor I and insulin-like growth factor I receptor with the clinicopathological features and prognosis of patients with colon cancer.
    Han L; Zhang GF; Cheng YH; Zhao QC
    Jpn J Clin Oncol; 2016 Dec; 46(12):1127-1134. PubMed ID: 27737962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls.
    Chang HP; Yang SF; Wang SL; Su PH
    BMC Endocr Disord; 2018 Sep; 18(1):66. PubMed ID: 30249230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between insulin‑like growth factor binding protein 3 and metastasis‑associated gene 1 protein in esophageal squamous cell carcinoma.
    Yang H; Xu L; Qian H; Niu X; Zhao D; Zhao Z; Wu J; Liu J; Wang Y
    Mol Med Rep; 2016 May; 13(5):4143-50. PubMed ID: 27035126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of polymorphisms in genes encoding for insulin-like growth factor (IGF)-I, insulin, and IGF-binding protein (IGFBP)-3 on IGF-I, IGF-II, and IGFBP-3 levels in umbilical cord plasma.
    Landmann E; Kollerits B; Kreuder JG; Blum WF; Kronenberg F; Rudloff S
    Horm Res Paediatr; 2012; 77(6):341-50. PubMed ID: 22739332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.
    Jin M; Long ZW; Yang J; Lin X
    Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite polymorphism in the P1 promoter region of the IGF‑1 gene is associated with endometrial cancer.
    Kwasniewski W; Gozdzicka-Jozefiak A; Wolun-Cholewa M; Polak G; Sierocinska-Sawa J; Kwasniewska A; Kotarski J
    Mol Med Rep; 2016 Jun; 13(6):4950-8. PubMed ID: 27121258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in human esophageal cancer.
    Sohda M; Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Fukai Y; Masuda N; Kuwano H
    Anticancer Res; 2004; 24(5A):3029-34. PubMed ID: 15517912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between gene expression of IGF-1R pathway markers and cetuximab benefit in metastatic colorectal cancer.
    Huang F; Xu LA; Khambata-Ford S
    Clin Cancer Res; 2012 Feb; 18(4):1156-66. PubMed ID: 22294722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated IGFBP3 levels in diabetic tears: a negative regulator of IGF-1 signaling in the corneal epithelium.
    Wu YC; Buckner BR; Zhu M; Cavanagh HD; Robertson DM
    Ocul Surf; 2012 Apr; 10(2):100-7. PubMed ID: 22482470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of silencing C-erbB-2 on esophageal carcinoma cell biological behaviors by inhibiting IGF-1 pathway activation.
    Niu Z; Zhang W; Shi J; Li X; Wu H
    J Cardiothorac Surg; 2021 Jul; 16(1):194. PubMed ID: 34233689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.